Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy

Autogenerated by for
Created on Tue, 2020-06-02 13:33, last updated on Tue, 2020-06-02 13:33

Vertical Tabs

QR Code for https://3dprint.nih.gov/discover/3dpx-014489

Rating

No votes yet

Licensing

Comments